company background image
BNR logo

Burning Rock Biotech NasdaqGM:BNR Voorraadrapport

Laatste prijs

US$2.80

Marktkapitalisatie

US$28.7m

7D

-1.8%

1Y

-72.3%

Bijgewerkt

04 Nov, 2024

Gegevens

Financiële gegevens bedrijf

Burning Rock Biotech Limited

NasdaqGM:BNR Voorraadrapport

Marktkapitalisatie: US$28.7m

BNR Overzicht aandelen

Burning Rock Biotech Limited ontwikkelt en verkoopt voornamelijk kankertherapie selectietests in de Volksrepubliek China.

Burning Rock Biotech Limited Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Burning Rock Biotech
Historische aandelenkoersen
Huidige aandelenkoersUS$2.80
52 Week HoogtepuntUS$10.50
52 Week LaagUS$2.62
Bèta0.13
11 maand verandering-24.53%
3 maanden verandering-56.45%
1 Jaar Verandering-72.28%
33 jaar verandering-98.06%
5 jaar veranderingn/a
Verandering sinds IPO-98.86%

Recent nieuws en updates

Little Excitement Around Burning Rock Biotech Limited's (NASDAQ:BNR) Revenues

Jun 21
Little Excitement Around Burning Rock Biotech Limited's (NASDAQ:BNR) Revenues

Recent updates

Little Excitement Around Burning Rock Biotech Limited's (NASDAQ:BNR) Revenues

Jun 21
Little Excitement Around Burning Rock Biotech Limited's (NASDAQ:BNR) Revenues

Will Burning Rock Biotech (NASDAQ:BNR) Spend Its Cash Wisely?

Mar 25
Will Burning Rock Biotech (NASDAQ:BNR) Spend Its Cash Wisely?

There's No Escaping Burning Rock Biotech Limited's (NASDAQ:BNR) Muted Revenues

Feb 01
There's No Escaping Burning Rock Biotech Limited's (NASDAQ:BNR) Muted Revenues

Burning Rock Biotech Limited (NASDAQ:BNR) Shares Could Be 24% Below Their Intrinsic Value Estimate

Jul 12
Burning Rock Biotech Limited (NASDAQ:BNR) Shares Could Be 24% Below Their Intrinsic Value Estimate

Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Deliver On Growth Plans?

Apr 28
Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Deliver On Growth Plans?

We Think Burning Rock Biotech (NASDAQ:BNR) Needs To Drive Business Growth Carefully

Dec 23
We Think Burning Rock Biotech (NASDAQ:BNR) Needs To Drive Business Growth Carefully

Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Invest In Growth?

Sep 20
Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Invest In Growth?

Burning Rock Biotech GAAP EPS of -$0.37 misses by $0.01, revenue of $19.5M misses by $2.94M

Aug 31

Burning Rock Localizes As Investors Grow Impatient

Jun 06

We're Hopeful That Burning Rock Biotech (NASDAQ:BNR) Will Use Its Cash Wisely

Mar 24
We're Hopeful That Burning Rock Biotech (NASDAQ:BNR) Will Use Its Cash Wisely

Following Rough Year, Is Burning Rock Set To Turn The Corner?

Nov 17

Is Burning Rock Biotech (NASDAQ:BNR) Using Debt In A Risky Way?

Aug 27
Is Burning Rock Biotech (NASDAQ:BNR) Using Debt In A Risky Way?

A Look At The Intrinsic Value Of Burning Rock Biotech Limited (NASDAQ:BNR)

Jul 23
A Look At The Intrinsic Value Of Burning Rock Biotech Limited (NASDAQ:BNR)

Is Burning Rock Biotech (NASDAQ:BNR) Using Debt Sensibly?

May 13
Is Burning Rock Biotech (NASDAQ:BNR) Using Debt Sensibly?

Burning Rock Biotech Expands Test Portfolio In Bid For Growth

Dec 30

Burning Rock inks license pact with Oncocyte Corporation

Dec 15

Burning Rock Biotech prices upsized offering of 2.243M ADSs at $25.75/ADS

Dec 04

Burning Rock Biotech EPS misses by $0.08, beats on revenue

Nov 20

Rendement voor aandeelhouders

BNRUS BiotechsUS Markt
7D-1.8%-0.7%-1.6%
1Y-72.3%19.8%30.8%

Rendement versus industrie: BNR underperformed the US Biotechs industry which returned 19.8% over the past year.

Rendement versus markt: BNR underperformed the US Market which returned 30.8% over the past year.

Prijsvolatiliteit

Is BNR's price volatile compared to industry and market?
BNR volatility
BNR Average Weekly Movement14.2%
Biotechs Industry Average Movement9.6%
Market Average Movement6.0%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

Stabiele aandelenkoers: BNR's share price has been volatile over the past 3 months compared to the US market.

Volatiliteit in de loop van de tijd: BNR's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
2014786Yusheng Hanwww.brbiotech.com

Burning Rock Biotech Limited ontwikkelt en verkoopt voornamelijk kankertherapie selectietesten in de Volksrepubliek China. Het bedrijf is actief in drie segmenten: Central Laboratory Business, In-Hospital Business en Pharma Research and Development Services. Het bedrijf biedt voornamelijk op next-generation sequencing gebaseerde weefsel- en vloeibare biopsietests voor kankerselectie en prognosevoorspelling voor verschillende soorten kanker, waaronder longkanker, maag- en darmkanker, prostaatkanker, borstkanker, lymfomen, schildklierkanker, colorectale kanker, eierstokkanker, alvleesklierkanker en blaaskanker met behulp van weefsel- en vloeibare biopsiestalen.

Burning Rock Biotech Limited Samenvatting

Hoe verhouden de winst en inkomsten van Burning Rock Biotech zich tot de beurswaarde?
BNR fundamentele statistieken
MarktkapitalisatieUS$28.72m
Inkomsten(TTM)-US$79.59m
Inkomsten(TTM)US$71.59m

0.4x

P/S-verhouding

-0.4x

Koers/Winstverhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
BNR resultatenrekening (TTM)
InkomstenCN¥509.81m
Kosten van inkomstenCN¥164.64m
BrutowinstCN¥345.17m
Overige uitgavenCN¥911.95m
Inkomsten-CN¥566.78m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)-55.25
Brutomarge67.71%
Nettowinstmarge-111.18%
Schuld/Eigen Vermogen Verhouding0%

Hoe presteerde BNR op de lange termijn?

Bekijk historische prestaties en vergelijking